Michael Vogelbaum

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Michael Vogelbaum

Nov 12, 2024, 16:05 | Blog

A 2 part update on AI-RANO published on The Lancet Oncology

Vivek Subbiah posted on LinkedIn about recent paper by Javier E Villanueva-Meyer et al., titled "Artificial…

Oct 7, 2024, 18:56 | Blog

Michael Vogelbaum: Congress of Neurological Surgeons Annual Meeting Brain Tumor update

Michael Vogelbaum, Program Leader for NeuroOncology and Chief of Neurosurgery at Moffitt Cancer Center, shared…

Aug 29, 2024, 16:48 | Insight

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe

JAMA Oncology shared a post on X about a recent paper by Kamran Ahmed et…

Aug 19, 2024, 09:44 | Insight

Narjust Florez: Interesting and hypothesis provoking research letter in JAMA Oncology

Narjust Florez shared a post on X by JAMA Oncology about a recent paper by…

Jun 26, 2024, 01:56 | Insight

Activity of macrophages in tumors remain poorly defined

Patrick Hwu shared on X: "The metabolic networks regulating the activity of macrophages in tumors…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023